StemSight

StemSight Develops Off-the-Shelf Regenerative Cell Therapy for Corneal Blindness. Our expertise lies in combining iPSC-derived cells with functional biomaterials to achieve faster tissue regeneration, safer cell therapy, and easier cell delivery.